{"SPADE_UN_07003": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2012/0157374 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2012_0157374_A1", "Patent Type": "Patent Application", "Publication Date": "2012-6-21", "Family Info": "EP2269627A1,EP2442823A1,WO2010146067A1", "Patent Title": "Nodule specific medicago peptides having antimicrobial activity and pharmaceutical compositions containging the same.", "Abstract": "The present invention relates to the use of at least one peptide originated from Medicago truncatula nodules, including the SEQ IDs NO: 1-463 or at least one peptide having a sequence derived from the SEQ IDs NO: 1-463 by deletion of about 9 to about 44 contiguous amino acids, from the N-terminal part of the peptide, in particular peptides having the SEQ IDS NO: 464 to 925, for the preparation of a drug intended for the treatment of human, animal or plant diseases induced by microorganisms, wherein the peptides have a broad-spectrum and fast antibiotic activity, in particular killing of the bacteria within 1 to 3 hours."}], "Sequence Information": {"SPADE ID": "SPADE_UN_07003", "Sequence": "MAKILKFVYVPILYLSILLVLTIYDQVYFNYNPPCVSDKDCPSPKSPKSNIRCRQGYCVNLYS", "Sequence Length": 63, "Peptide Name": "Sequence 365 from Patent US 20120157374", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "LYP", "Absent Amino Acids": "EHOUW", "Basic Residues": 7, "Acidic Residues": 3, "Hydrophobic Residues": 35, "Polar Residues": 38, "Positive Residues": 7, "Negative Residues": 3, "Mass": 7296.57, "PI": 8.98, "Net Charge": 4, "Hydrophobicity": 0.14, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_07453", "Similarity": 1.0, "Sequence": "NYNPPCVSDKDCPSPKSPKSNIRCRQGYCVNLYS"}, {"SPADE_ID": "SPADE_UN_06678", "Similarity": 0.8253968253968254, "Sequence": "MAKILKFVYVPILYLSILLVLTIYDQVYFNNSPPCVTDKDCPRPQFRKSNVRCRNGYCVNLGN"}, {"SPADE_ID": "SPADE_UN_06677", "Similarity": 0.8095238095238095, "Sequence": "MAKILKFVYVPILYFSILLVLTIYDQAYFNDPRPCVSDKDCPRPKFQKSNVRCRKGYCVNLDG"}]}}}